SFX by Ex Libris Inc.

Title:	Overexpression of alcohol oxidase inPichia pastoris
Source:	Febs Letters [0014-5793] de Hoop, M J yr:1991

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Evan, G. "Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product." Molecular and cellular biology 5.12 (1985): 3610-6.
description	2.	Pelengaris, S. "c-MYC: more than just a matter of life and death." Nature reviews. Cancer 2.10 (2002): 764-76.
description	3.	Ottone, Sophie, S. "Expression of hepatitis B surface antigen major subtypes in Pichia pastoris and purification for in vitro diagnosis." Protein expression and purification 56.2 (2007): 177-188.
description	4.	Zhou, G. "2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers." Molecular & cellular proteomics 1.2 (2002): 117-124.
description	5.	Cobleigh, M A A. "Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease." Journal of clinical oncology 17.9 (1999): 2639-48.
description	6.	de StGroth, D F. "Production of monoclonal antibodies: strategy and tactics." Journal of immunological methods 35.1-2 (1980): 1-21.
description	7.	Cobleigh, M. "A case of herceptin cardiotoxicity." American journal of therapeutics 11.1 (2004): 74-76.
description	8.	Stewart, Charles L N. "Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer." Journal of clinical oncology 20.3 (2002): 719-26.
description	9.	Dang, Chi V. "MYC on the Path to Cancer." Cell 149.1 (2012): 22-35.
description	10.	Soucek, L. "The ups and downs of Myc biology." Current opinion in genetics & development 20.1 (2010): 91-95.
description	11.	Müller, R. "Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay." Methods Enzymol 92 (1983): 589-601.
description	12.	Pelengaris, S. "Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression." Cell 109.3 (2002): 321-334.
description	13.	Meyer, N. "Reflecting on 25 years with MYC." Nature reviews. Cancer 8.12 (2008): 976-990.
description	14.	Baselga, J. "Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts." Cancer research 58.13 (1998): 2825-31.
description	15.	Houghton, A N N. "Monoclonal antibody therapies-a 'constant' threat to cancer." Nature medicine 6.4 (2000): 373-4.
description	16.	Adhikary, S. "Transcriptional regulation and transformation by Myc proteins." Nature reviews. Molecular cell biology 6.8 (2005): 635-45.
description	17.	Milstein, G. "Continuous cultures of fused cells secreting antibody of predefined specificity." Nature 256.5517 (1975): 495-7.
description	18.	Liu, R. "Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast pichia pastoris." Applied biochemistry and biotechnology 158.2 (2009): 432-444.
description	19.	Guo, M. "A systematical investigation on the genetic stability of multi-copy Pichia pastoris strains." Biotechnology letters 31.5 (2009): 679-684.
description	20.	Vogel, Henry C. C. Fermentation and Biochemical Engineering Handbook - Principles, Process Design, and Equipment (2nd Edition). 1997. 242-270.